# Filing Detail

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0000939767-25-000063
Filing Date
2025-04-16
Accepted
2025-04-16 16:29:31
Documents
4

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEFA14A | exel-2025proxystatementnot.htm | DEFA14A | 10763
2 |  | a2023logo.jpg | GRAPHIC | 12387
3 |  | exelixisinc_vxqmxnaxp28034.jpg | GRAPHIC | 486299
4 |  | exelixisinc_vxqmxnaxp28034a.jpg | GRAPHIC | 477931
| Complete submission text file | 0000939767-25-000063.txt |  | 1356604

Mailing Address 1851 HARBOR BAY PARKWAY ALAMEDA CA 94502
Business Address 1851 HARBOR BAY PARKWAY ALAMEDA CA 94502 6508377000
EXELIXIS, INC. (Filer) CIK: 0000939767 (see all company filings)

EIN.: 043257395 | State of Incorp.: DE | Fiscal Year End: 0103
Type: DEFA14A | Act: 34 | File No.: 000-30235 | Film No.: 25843138
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)